A detailed history of Key F Inancial Inc transactions in Incyte Corp stock. As of the latest transaction made, Key F Inancial Inc holds 50 shares of INCY stock, worth $3,686. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 50 -0.0%
Holding current value
$3,686
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

SELL
$70.23 - $86.01 $912,990 - $1.12 Million
-13,000 Reduced 99.62%
50 $3,000
Q3 2022

Oct 28, 2022

BUY
$66.18 - $82.86 $3,309 - $4,143
50 Added 0.38%
13,050 $870,000
Q1 2022

Apr 27, 2022

SELL
$66.02 - $79.71 $3.47 Million - $4.19 Million
-52,533 Reduced 80.16%
13,000 $1.03 Million
Q4 2020

Jan 29, 2021

BUY
$80.74 - $97.7 $1.05 Million - $1.27 Million
13,000 Added 24.75%
65,533 $5.7 Million
Q4 2019

Feb 11, 2020

BUY
$73.04 - $95.72 $3.84 Million - $5.03 Million
52,533 New
52,533 $4.59 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Key F Inancial Inc Portfolio

Follow Key F Inancial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.